TapewireFind a company

person · Reporting owner

LeMaitre George W

Disclosed activity across 1 company

Tapewire entity
41061
SEC CIK
0001365737

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
LEMAITRE VASCULAR INCLMAT · Entity 1927Director · Chairman and CEOSeptember 03, 2026September 08, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

LEMAITRE VASCULAR INC

Report date September 03, 2026 · Filed September 08, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Dividend Equivalent RightsSEC Table II · derivative / convertible securityDirect54.005 Reported balance After 2026-09-03 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-09-03 · Grant · Acquired 4.6726 · Balance 54.005

F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Dividend Equivalent RightsSEC Table II · derivative / convertible securityDirect53.2963 Reported balance After 2026-09-03 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-09-03 · Grant · Acquired 4.6726 · Balance 53.2963

F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Dividend Equivalent RightsSEC Table II · derivative / convertible securityDirect65.3344 Reported balance After 2026-09-03 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2026-09-03 · Grant · Acquired 7.9884 · Balance 65.3344

F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Dividend Equivalent RightsSEC Table II · derivative / convertible securityDirect70.4281 Reported balance After 2026-09-03 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2026-09-03 · Grant · Acquired 9.5728 · Balance 70.4281

F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Dividend Equivalent RightsSEC Table II · derivative / convertible securityDirect65.0639 Reported balance After 2026-09-03 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2026-09-03 · Grant · Acquired 11.6845 · Balance 65.0639

F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Dividend Equivalent RightsSEC Table II · derivative / convertible securityDirect67.0809 Reported balance After 2026-09-03 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2026-09-03 · Grant · Acquired 13.2391 · Balance 67.0809

F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Dividend Equivalent RightsSEC Table II · derivative / convertible securityDirect50.6104 Reported balance After 2026-09-03 transaction · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · 2026-09-03 · Grant · Acquired 19.5865 · Balance 50.6104

F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Filing footnotes · ownership attribution and instrument terms

F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
December 11, 2025 Filed Dec 15, 2025 23:14 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 54 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-319553 · ownership.xml · nonDerivative · entry 1

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,670,159

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

Read SEC document
December 10, 2025 Filed Dec 11, 2025 23:10 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantStock Option (Right to Buy) · Derivative 38,518 $0.00 Strike: $83.66 $0.00
Disclosure

SEC source: 0001193125-25-316352 · ownership.xml · derivative · entry 3

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,518

Underlying: Common Stock · 38,518 shares

Expires 2032-12-10

F3 · derivative.exercise_date: This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years.

Read SEC document
December 10, 2025 Filed Dec 11, 2025 23:10 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantCommon Stock 6,275 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-316352 · ownership.xml · nonDerivative · entry 1

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,670,105

F1 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 25% of the award vests on 12/1/2026, with the balance vesting in equal annual installments over the remaining three years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 00:28 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionDividend Equivalent Rights · Derivative 25 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-314629 · ownership.xml · derivative · entry 7

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45.6923

Underlying: Common Stock · 25 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F6 · shares: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F6 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F6 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 00:28 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionDividend Equivalent Rights · Derivative 21 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-314629 · ownership.xml · derivative · entry 6

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44.693

Underlying: Common Stock · 21 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 00:28 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Tax withholdingCommon Stock 681 $82.93 $56,475.33
Disclosure

SEC source: 0001193125-25-314629 · ownership.xml · nonDerivative · entry 4

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,663,830

F3 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units awarded to the reporting person on 12/8/2023. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 00:28 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 25 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-314629 · ownership.xml · nonDerivative · entry 3

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,664,511

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 00:28 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Tax withholdingCommon Stock 567 $82.93 $47,021.31
Disclosure

SEC source: 0001193125-25-314629 · ownership.xml · nonDerivative · entry 2

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,664,486

F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/8/2023. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 00:28 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 21 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-314629 · ownership.xml · nonDerivative · entry 1

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,665,053

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

Read SEC document
December 06, 2025 Filed Dec 9, 2025 01:18 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionDividend Equivalent Rights · Derivative 11 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-311602 · ownership.xml · derivative · entry 10

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34.8716

Underlying: Common Stock · 11 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/6/2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F10 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/6/2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F10 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/6/2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F10 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/6/2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 06, 2025 Filed Dec 9, 2025 01:18 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Tax withholdingCommon Stock 553 $84.53 $46,745.09
Disclosure

SEC source: 0001193125-25-311602 · ownership.xml · nonDerivative · entry 2

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,665,032

F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/6/2024. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.

Read SEC document
December 06, 2025 Filed Dec 9, 2025 01:18 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 11 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-311602 · ownership.xml · nonDerivative · entry 1

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,665,585

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

Read SEC document
December 04, 2025 Filed Dec 9, 2025 01:18 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 11.62 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-311602 · ownership.xml · derivative · entry 9

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45.8716

Underlying: Common Stock · 11.62 shares

Expires not disclosed

F9 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F9 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F9 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 04, 2025 Filed Dec 9, 2025 01:18 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 10.7112 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-311602 · ownership.xml · derivative · entry 8

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70.6923

Underlying: Common Stock · 10.7112 shares

Expires not disclosed

F8 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F8 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F8 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 04, 2025 Filed Dec 9, 2025 01:18 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 8.9379 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-311602 · ownership.xml · derivative · entry 7

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65.693

Underlying: Common Stock · 8.9379 shares

Expires not disclosed

F7 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F7 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F7 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 04, 2025 Filed Dec 9, 2025 01:18 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 6.9708 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-311602 · ownership.xml · derivative · entry 6

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80.2224

Underlying: Common Stock · 6.9708 shares

Expires not disclosed

F6 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F6 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F6 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 04, 2025 Filed Dec 9, 2025 01:18 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 6.9708 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-311602 · ownership.xml · derivative · entry 5

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80.9311

Underlying: Common Stock · 6.9708 shares

Expires not disclosed

F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 04, 2025 Filed Dec 9, 2025 01:18 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 3.4203 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-311602 · ownership.xml · derivative · entry 4

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56.3976

Underlying: Common Stock · 3.4203 shares

Expires not disclosed

F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 02, 2025 Filed Dec 4, 2025 00:39 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionDividend Equivalent Rights · Derivative 45 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-307161 · ownership.xml · derivative · entry 4

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 45 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · balance_after: Fractional shares released (if any) on each vesting date were settled in cash, resulting in a final balance of zero.

Read SEC document
December 02, 2025 Filed Dec 4, 2025 00:39 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Tax withholdingCommon Stock 455 $83.68 $38,074.40
Disclosure

SEC source: 0001193125-25-307161 · ownership.xml · nonDerivative · entry 2

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,665,574

F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 2, 2020. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.

Read SEC document
December 02, 2025 Filed Dec 4, 2025 00:39 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 45 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-307161 · ownership.xml · nonDerivative · entry 1

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,666,029

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

Read SEC document
November 20, 2025 Filed Nov 21, 2025 22:36 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionStock Option (Right to Buy) · Derivative 2,681 $0.00 Strike: $41.02 $0.00
Disclosure

SEC source: 0001193125-25-291658 · ownership.xml · derivative · entry 3

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,681 shares

Expires 2025-12-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
November 20, 2025 Filed Nov 21, 2025 22:36 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 2,681 $41.02 $109,974.62
Disclosure

SEC source: 0001193125-25-291658 · ownership.xml · nonDerivative · entry 1

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,665,984

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.

Read SEC document
September 05, 2025 Filed Sep 9, 2025 20:40 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantCommon Stock 21,300 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-028697 · rdgdoc.xml · nonDerivative · entry 4

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025

Disclosed balance after: 21,300

F1 · ownership.nature: These shares are held by an irrevocable trust for the benefit of Reporting Person's child(ren). The Reporting Person disclaims ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose.

Read SEC document
September 05, 2025 Filed Sep 9, 2025 20:40 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GiftCommon Stock 21,300 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-028697 · rdgdoc.xml · nonDerivative · entry 3

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,663,303

Read SEC document
September 05, 2025 Filed Sep 9, 2025 20:40 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GiftCommon Stock 10,600 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-028697 · rdgdoc.xml · nonDerivative · entry 2

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,684,603

Read SEC document
September 05, 2025 Filed Sep 9, 2025 20:40 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GiftCommon Stock 10,600 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-028697 · rdgdoc.xml · nonDerivative · entry 1

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,695,203

Read SEC document
September 04, 2025 Filed Sep 6, 2025 00:59 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 10.238 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-028513 · rdgdoc.xml · derivative · entry 9

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34.2516

Underlying: Common Stock · 10.238 shares

Expires not disclosed

F7 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F7 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F7 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
September 04, 2025 Filed Sep 6, 2025 00:59 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 9.4371 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-028513 · rdgdoc.xml · derivative · entry 8

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59.9811

Underlying: Common Stock · 9.4371 shares

Expires not disclosed

F6 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F6 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F6 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
September 04, 2025 Filed Sep 6, 2025 00:59 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 7.8747 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-028513 · rdgdoc.xml · derivative · entry 7

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56.7551

Underlying: Common Stock · 7.8747 shares

Expires not disclosed

F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
September 04, 2025 Filed Sep 6, 2025 00:59 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 6.1418 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-028513 · rdgdoc.xml · derivative · entry 6

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73.2516

Underlying: Common Stock · 6.1418 shares

Expires not disclosed

F4 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
September 04, 2025 Filed Sep 6, 2025 00:59 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 6.1418 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-028513 · rdgdoc.xml · derivative · entry 5

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73.9603

Underlying: Common Stock · 6.1418 shares

Expires not disclosed

F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
September 04, 2025 Filed Sep 6, 2025 00:59 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 3.0132 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-028513 · rdgdoc.xml · derivative · entry 4

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52.9773

Underlying: Common Stock · 3.0132 shares

Expires not disclosed

F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
September 04, 2025 Filed Sep 6, 2025 00:59 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 2.0944 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-028513 · rdgdoc.xml · derivative · entry 3

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48.5172

Underlying: Common Stock · 2.0944 shares

Expires not disclosed

F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
September 03, 2025 Filed Sep 6, 2025 00:59 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GiftCommon Stock 10,600 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-028513 · rdgdoc.xml · nonDerivative · entry 2

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,705,803

Read SEC document
September 03, 2025 Filed Sep 6, 2025 00:59 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GiftCommon Stock 10,600 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-028513 · rdgdoc.xml · nonDerivative · entry 1

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,716,403

Read SEC document
August 06, 2025 Filed Aug 8, 2025 21:48 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 SaleCommon Stock 100,000 $93.51 $9,350,530.00
Disclosure

SEC source: 0001437749-25-025775 · rdgdoc.xml · nonDerivative · entry 1

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,727,003

F1 · price: Adoption date of referenced 10b5-1(c) plan is: 03-10-2025

F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $93.03 to $94.00. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:14 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 12.2285 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-019157 · rdgdoc.xml · derivative · entry 7

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24.0136

Underlying: Common Stock · 12.2285 shares

Expires not disclosed

F7 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F7 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F7 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:14 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 11.2713 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-019157 · rdgdoc.xml · derivative · entry 6

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50.544

Underlying: Common Stock · 11.2713 shares

Expires not disclosed

F6 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F6 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F6 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:14 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 9.4056 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-019157 · rdgdoc.xml · derivative · entry 5

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48.8804

Underlying: Common Stock · 9.4056 shares

Expires not disclosed

F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:14 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 7.3356 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-019157 · rdgdoc.xml · derivative · entry 4

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67.1098

Underlying: Common Stock · 7.3356 shares

Expires not disclosed

F4 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:14 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 7.3356 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-019157 · rdgdoc.xml · derivative · entry 3

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67.8185

Underlying: Common Stock · 7.3356 shares

Expires not disclosed

F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:14 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 3.5993 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-019157 · rdgdoc.xml · derivative · entry 2

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49.9641

Underlying: Common Stock · 3.5993 shares

Expires not disclosed

F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:14 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 2.501 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-019157 · rdgdoc.xml · derivative · entry 1

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46.4228

Underlying: Common Stock · 2.501 shares

Expires not disclosed

F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
May 20, 2025 Filed May 20, 2025 23:11 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionStock Option (Right to Buy) · Derivative 6,182 $0.00 Strike: $54.65 $0.00
Disclosure

SEC source: 0001437749-25-017883 · rdgdoc.xml · derivative · entry 15

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,373

Underlying: Common Stock · 6,182 shares

Expires 2030-12-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years.

Read SEC document
May 20, 2025 Filed May 20, 2025 23:11 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionStock Option (Right to Buy) · Derivative 7,075 $0.00 Strike: $47.19 $0.00
Disclosure

SEC source: 0001437749-25-017883 · rdgdoc.xml · derivative · entry 14

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,269

Underlying: Common Stock · 7,075 shares

Expires 2029-12-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years.

Read SEC document
May 20, 2025 Filed May 20, 2025 23:11 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionStock Option (Right to Buy) · Derivative 7,734 $0.00 Strike: $48.60 $0.00
Disclosure

SEC source: 0001437749-25-017883 · rdgdoc.xml · derivative · entry 13

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,733

Underlying: Common Stock · 7,734 shares

Expires 2028-12-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years.

Read SEC document
May 20, 2025 Filed May 20, 2025 23:11 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionStock Option (Right to Buy) · Derivative 7,836 $0.00 Strike: $37.29 $0.00
Disclosure

SEC source: 0001437749-25-017883 · rdgdoc.xml · derivative · entry 12

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,836

Underlying: Common Stock · 7,836 shares

Expires 2027-12-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years.

Read SEC document
May 20, 2025 Filed May 20, 2025 23:11 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionStock Option (Right to Buy) · Derivative 5,792 $0.00 Strike: $35.48 $0.00
Disclosure

SEC source: 0001437749-25-017883 · rdgdoc.xml · derivative · entry 11

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,792 shares

Expires 2026-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years.

Read SEC document
May 20, 2025 Filed May 20, 2025 23:11 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 SaleCommon Stock 1,099 $84.69 $93,077.17
Disclosure

SEC source: 0001437749-25-017883 · rdgdoc.xml · nonDerivative · entry 10

LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,827,003

F6 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $84.23 to $84.88. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.